Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved

<i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study contro...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Cristian Parra-Sepúlveda [verfasserIn] Kimberly Sánchez-Alonzo [verfasserIn] Joaquín Olivares-Muñoz [verfasserIn] Cristian Gutiérrez-Zamorano [verfasserIn] Carlos T. Smith [verfasserIn] Romina I. Carvajal [verfasserIn] Katia Sáez-Carrillo [verfasserIn] Carlos González [verfasserIn] Apolinaria García-Cancino [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2022

Schlagwörter:	probiotic anti- prevention

Übergeordnetes Werk:	In: Foods - MDPI AG, 2013, 11(2022), 12, p 1668
Übergeordnetes Werk:	volume:11 ; year:2022 ; number:12, p 1668

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.3390/foods11121668

Katalog-ID:	DOAJ028441281

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ028441281
003	DE-627
005	20240414203724.0
007	cr uuu---uuuuu
008	230226s2022 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.3390/foods11121668 \|2 doi
035			\|a (DE-627)DOAJ028441281
035			\|a (DE-599)DOAJd25b83e88a874315b16fe891f0494827
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a TP1-1185
100	0		\|a Cristian Parra-Sepúlveda \|e verfasserin \|4 aut
245	1	0	\|a Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a <i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals.
650		4	\|a <i<Helicobacter pylori</i<
650		4	\|a probiotic
650		4	\|a <i<Limosilactobacillus fermentum</i<
650		4	\|a anti-<i<H. pylori</i< activity
650		4	\|a prevention
653		0	\|a Chemical technology
700	0		\|a Kimberly Sánchez-Alonzo \|e verfasserin \|4 aut
700	0		\|a Joaquín Olivares-Muñoz \|e verfasserin \|4 aut
700	0		\|a Cristian Gutiérrez-Zamorano \|e verfasserin \|4 aut
700	0		\|a Carlos T. Smith \|e verfasserin \|4 aut
700	0		\|a Romina I. Carvajal \|e verfasserin \|4 aut
700	0		\|a Katia Sáez-Carrillo \|e verfasserin \|4 aut
700	0		\|a Carlos González \|e verfasserin \|4 aut
700	0		\|a Apolinaria García-Cancino \|e verfasserin \|4 aut
773	0	8	\|i In \|t Foods \|d MDPI AG, 2013 \|g 11(2022), 12, p 1668 \|w (DE-627)737287632 \|w (DE-600)2704223-6 \|x 23048158 \|7 nnns
773	1	8	\|g volume:11 \|g year:2022 \|g number:12, p 1668
856	4	0	\|u https://doi.org/10.3390/foods11121668 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/d25b83e88a874315b16fe891f0494827 \|z kostenfrei
856	4	0	\|u https://www.mdpi.com/2304-8158/11/12/1668 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2304-8158 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 11 \|j 2022 \|e 12, p 1668

Indexfelder

author_variant	c p s cps k s a ksa j o m jom c g z cgz c t s cts r i c ric k s c ksc c g cg a g c agc
matchkey_str	article:23048158:2022----::osmtooaeaisplmnewtterboisriiioiatbclufretmuo7crvnshlcbceplri
hierarchy_sort_str	2022
callnumber-subject-code	TP
publishDate	2022
allfields	10.3390/foods11121668 doi (DE-627)DOAJ028441281 (DE-599)DOAJd25b83e88a874315b16fe891f0494827 DE-627 ger DE-627 rakwb eng TP1-1185 Cristian Parra-Sepúlveda verfasserin aut Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals. <i<Helicobacter pylori</i< probiotic <i<Limosilactobacillus fermentum</i< anti-<i<H. pylori</i< activity prevention Chemical technology Kimberly Sánchez-Alonzo verfasserin aut Joaquín Olivares-Muñoz verfasserin aut Cristian Gutiérrez-Zamorano verfasserin aut Carlos T. Smith verfasserin aut Romina I. Carvajal verfasserin aut Katia Sáez-Carrillo verfasserin aut Carlos González verfasserin aut Apolinaria García-Cancino verfasserin aut In Foods MDPI AG, 2013 11(2022), 12, p 1668 (DE-627)737287632 (DE-600)2704223-6 23048158 nnns volume:11 year:2022 number:12, p 1668 https://doi.org/10.3390/foods11121668 kostenfrei https://doaj.org/article/d25b83e88a874315b16fe891f0494827 kostenfrei https://www.mdpi.com/2304-8158/11/12/1668 kostenfrei https://doaj.org/toc/2304-8158 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 12, p 1668
spelling	10.3390/foods11121668 doi (DE-627)DOAJ028441281 (DE-599)DOAJd25b83e88a874315b16fe891f0494827 DE-627 ger DE-627 rakwb eng TP1-1185 Cristian Parra-Sepúlveda verfasserin aut Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals. <i<Helicobacter pylori</i< probiotic <i<Limosilactobacillus fermentum</i< anti-<i<H. pylori</i< activity prevention Chemical technology Kimberly Sánchez-Alonzo verfasserin aut Joaquín Olivares-Muñoz verfasserin aut Cristian Gutiérrez-Zamorano verfasserin aut Carlos T. Smith verfasserin aut Romina I. Carvajal verfasserin aut Katia Sáez-Carrillo verfasserin aut Carlos González verfasserin aut Apolinaria García-Cancino verfasserin aut In Foods MDPI AG, 2013 11(2022), 12, p 1668 (DE-627)737287632 (DE-600)2704223-6 23048158 nnns volume:11 year:2022 number:12, p 1668 https://doi.org/10.3390/foods11121668 kostenfrei https://doaj.org/article/d25b83e88a874315b16fe891f0494827 kostenfrei https://www.mdpi.com/2304-8158/11/12/1668 kostenfrei https://doaj.org/toc/2304-8158 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 12, p 1668
allfields_unstemmed	10.3390/foods11121668 doi (DE-627)DOAJ028441281 (DE-599)DOAJd25b83e88a874315b16fe891f0494827 DE-627 ger DE-627 rakwb eng TP1-1185 Cristian Parra-Sepúlveda verfasserin aut Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals. <i<Helicobacter pylori</i< probiotic <i<Limosilactobacillus fermentum</i< anti-<i<H. pylori</i< activity prevention Chemical technology Kimberly Sánchez-Alonzo verfasserin aut Joaquín Olivares-Muñoz verfasserin aut Cristian Gutiérrez-Zamorano verfasserin aut Carlos T. Smith verfasserin aut Romina I. Carvajal verfasserin aut Katia Sáez-Carrillo verfasserin aut Carlos González verfasserin aut Apolinaria García-Cancino verfasserin aut In Foods MDPI AG, 2013 11(2022), 12, p 1668 (DE-627)737287632 (DE-600)2704223-6 23048158 nnns volume:11 year:2022 number:12, p 1668 https://doi.org/10.3390/foods11121668 kostenfrei https://doaj.org/article/d25b83e88a874315b16fe891f0494827 kostenfrei https://www.mdpi.com/2304-8158/11/12/1668 kostenfrei https://doaj.org/toc/2304-8158 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 12, p 1668
allfieldsGer	10.3390/foods11121668 doi (DE-627)DOAJ028441281 (DE-599)DOAJd25b83e88a874315b16fe891f0494827 DE-627 ger DE-627 rakwb eng TP1-1185 Cristian Parra-Sepúlveda verfasserin aut Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals. <i<Helicobacter pylori</i< probiotic <i<Limosilactobacillus fermentum</i< anti-<i<H. pylori</i< activity prevention Chemical technology Kimberly Sánchez-Alonzo verfasserin aut Joaquín Olivares-Muñoz verfasserin aut Cristian Gutiérrez-Zamorano verfasserin aut Carlos T. Smith verfasserin aut Romina I. Carvajal verfasserin aut Katia Sáez-Carrillo verfasserin aut Carlos González verfasserin aut Apolinaria García-Cancino verfasserin aut In Foods MDPI AG, 2013 11(2022), 12, p 1668 (DE-627)737287632 (DE-600)2704223-6 23048158 nnns volume:11 year:2022 number:12, p 1668 https://doi.org/10.3390/foods11121668 kostenfrei https://doaj.org/article/d25b83e88a874315b16fe891f0494827 kostenfrei https://www.mdpi.com/2304-8158/11/12/1668 kostenfrei https://doaj.org/toc/2304-8158 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 12, p 1668
allfieldsSound	10.3390/foods11121668 doi (DE-627)DOAJ028441281 (DE-599)DOAJd25b83e88a874315b16fe891f0494827 DE-627 ger DE-627 rakwb eng TP1-1185 Cristian Parra-Sepúlveda verfasserin aut Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals. <i<Helicobacter pylori</i< probiotic <i<Limosilactobacillus fermentum</i< anti-<i<H. pylori</i< activity prevention Chemical technology Kimberly Sánchez-Alonzo verfasserin aut Joaquín Olivares-Muñoz verfasserin aut Cristian Gutiérrez-Zamorano verfasserin aut Carlos T. Smith verfasserin aut Romina I. Carvajal verfasserin aut Katia Sáez-Carrillo verfasserin aut Carlos González verfasserin aut Apolinaria García-Cancino verfasserin aut In Foods MDPI AG, 2013 11(2022), 12, p 1668 (DE-627)737287632 (DE-600)2704223-6 23048158 nnns volume:11 year:2022 number:12, p 1668 https://doi.org/10.3390/foods11121668 kostenfrei https://doaj.org/article/d25b83e88a874315b16fe891f0494827 kostenfrei https://www.mdpi.com/2304-8158/11/12/1668 kostenfrei https://doaj.org/toc/2304-8158 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2022 12, p 1668
language	English
source	In Foods 11(2022), 12, p 1668 volume:11 year:2022 number:12, p 1668
sourceStr	In Foods 11(2022), 12, p 1668 volume:11 year:2022 number:12, p 1668
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	<i<Helicobacter pylori</i< probiotic <i<Limosilactobacillus fermentum</i< anti-<i<H. pylori</i< activity prevention Chemical technology
isfreeaccess_bool	true
container_title	Foods
authorswithroles_txt_mv	Cristian Parra-Sepúlveda @@aut@@ Kimberly Sánchez-Alonzo @@aut@@ Joaquín Olivares-Muñoz @@aut@@ Cristian Gutiérrez-Zamorano @@aut@@ Carlos T. Smith @@aut@@ Romina I. Carvajal @@aut@@ Katia Sáez-Carrillo @@aut@@ Carlos González @@aut@@ Apolinaria García-Cancino @@aut@@
publishDateDaySort_date	2022-01-01T00:00:00Z
hierarchy_top_id	737287632
id	DOAJ028441281
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ028441281</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414203724.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/foods11121668</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ028441281</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd25b83e88a874315b16fe891f0494827</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TP1-1185</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Cristian Parra-Sepúlveda</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Helicobacter pylori</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">probiotic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Limosilactobacillus fermentum</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anti-<i<H. pylori</i< activity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prevention</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Chemical technology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kimberly Sánchez-Alonzo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Joaquín Olivares-Muñoz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Cristian Gutiérrez-Zamorano</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Carlos T. Smith</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Romina I. Carvajal</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katia Sáez-Carrillo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Carlos González</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Apolinaria García-Cancino</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Foods</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">11(2022), 12, p 1668</subfield><subfield code="w">(DE-627)737287632</subfield><subfield code="w">(DE-600)2704223-6</subfield><subfield code="x">23048158</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:12, p 1668</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/foods11121668</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d25b83e88a874315b16fe891f0494827</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2304-8158/11/12/1668</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2304-8158</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2022</subfield><subfield code="e">12, p 1668</subfield></datafield></record></collection>
callnumber-first	T - Technology
author	Cristian Parra-Sepúlveda
spellingShingle	Cristian Parra-Sepúlveda misc TP1-1185 misc <i<Helicobacter pylori</i< misc probiotic misc <i<Limosilactobacillus fermentum</i< misc anti-<i<H. pylori</i< activity misc prevention misc Chemical technology Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved
authorStr	Cristian Parra-Sepúlveda
ppnlink_with_tag_str_mv	@@773@@(DE-627)737287632
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	TP1-1185
illustrated	Not Illustrated
issn	23048158
topic_title	TP1-1185 Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved <i<Helicobacter pylori</i< probiotic <i<Limosilactobacillus fermentum</i< anti-<i<H. pylori</i< activity prevention
topic	misc TP1-1185 misc <i<Helicobacter pylori</i< misc probiotic misc <i<Limosilactobacillus fermentum</i< misc anti-<i<H. pylori</i< activity misc prevention misc Chemical technology
topic_unstemmed	misc TP1-1185 misc <i<Helicobacter pylori</i< misc probiotic misc <i<Limosilactobacillus fermentum</i< misc anti-<i<H. pylori</i< activity misc prevention misc Chemical technology
topic_browse	misc TP1-1185 misc <i<Helicobacter pylori</i< misc probiotic misc <i<Limosilactobacillus fermentum</i< misc anti-<i<H. pylori</i< activity misc prevention misc Chemical technology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Foods
hierarchy_parent_id	737287632
hierarchy_top_title	Foods
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)737287632 (DE-600)2704223-6
title	Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved
ctrlnum	(DE-627)DOAJ028441281 (DE-599)DOAJd25b83e88a874315b16fe891f0494827
title_full	Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved
author_sort	Cristian Parra-Sepúlveda
journal	Foods
journalStr	Foods
callnumber-first-code	T
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2022
contenttype_str_mv	txt
author_browse	Cristian Parra-Sepúlveda Kimberly Sánchez-Alonzo Joaquín Olivares-Muñoz Cristian Gutiérrez-Zamorano Carlos T. Smith Romina I. Carvajal Katia Sáez-Carrillo Carlos González Apolinaria García-Cancino
container_volume	11
class	TP1-1185
format_se	Elektronische Aufsätze
author-letter	Cristian Parra-Sepúlveda
doi_str_mv	10.3390/foods11121668
author2-role	verfasserin
title_sort	consumption of a gelatin supplemented with the probiotic strain <i<limosilactobacillus fermentum</i< uco-979c prevents <i<helicobacter pylori</i< infection in a young adult population achieved
callnumber	TP1-1185
title_auth	Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved
abstract	<i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals.
abstractGer	<i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals.
abstract_unstemmed	<i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	12, p 1668
title_short	Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved
url	https://doi.org/10.3390/foods11121668 https://doaj.org/article/d25b83e88a874315b16fe891f0494827 https://www.mdpi.com/2304-8158/11/12/1668 https://doaj.org/toc/2304-8158
remote_bool	true
author2	Kimberly Sánchez-Alonzo Joaquín Olivares-Muñoz Cristian Gutiérrez-Zamorano Carlos T. Smith Romina I. Carvajal Katia Sáez-Carrillo Carlos González Apolinaria García-Cancino
author2Str	Kimberly Sánchez-Alonzo Joaquín Olivares-Muñoz Cristian Gutiérrez-Zamorano Carlos T. Smith Romina I. Carvajal Katia Sáez-Carrillo Carlos González Apolinaria García-Cancino
ppnlink	737287632
callnumber-subject	TP - Chemical Technology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.3390/foods11121668
callnumber-a	TP1-1185
up_date	2024-07-03T17:36:42.116Z
_version_	1803580292065132544
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ028441281</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414203724.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/foods11121668</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ028441281</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd25b83e88a874315b16fe891f0494827</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TP1-1185</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Cristian Parra-Sepúlveda</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><i<Helicobacter pylori</i< is a bacterium associated with various gastrointestinal diseases of high worldwide prevalence. Since probiotics are an emerging alternative to managing infection by this pathogenic bacterium, the present work evaluated, in a randomized double-blind study controlled by a placebo, if consuming <i<Limosilactobacillus</i< <i<fermentum</i< UCO-979C prevents <i<H. pylori</i< infection in humans. Participants consumed either <i<L. fermentum</i< UCO-979C-supplemented gelatin (67 participants) or placebo-supplemented gelatin (64 participants) once a day, five days per week for 12 weeks. <i<H. pylori</i< infection in the participants was controlled before and after the intervention detecting <i<H. pylori</i< antigens in stools. Regarding <i<H. pylori</i<-infected participants before the study, 100% remained infected at the end of the study in the placebo group, while 96.7% of those receiving the probiotic remained infected after the intervention. Most importantly, of the non-infected participants, 34.2% became infected and 65.8% remained non-infected in the placebo group, while 2.7% became infected and 97.3% remained as non-infected individuals in the intervened group. Therefore, consuming the <i<L. fermentum</i< UCO-979C strain significantly reduced <i<H. pylori</i< infection, demonstrating a 92.6% efficacy in avoiding infection by this pathogen in non-infected individuals; thus, this probiotic is an excellent candidate to prevent <i<H. pylori</i< infections in non-infected individuals.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Helicobacter pylori</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">probiotic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Limosilactobacillus fermentum</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anti-<i<H. pylori</i< activity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">prevention</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Chemical technology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kimberly Sánchez-Alonzo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Joaquín Olivares-Muñoz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Cristian Gutiérrez-Zamorano</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Carlos T. Smith</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Romina I. Carvajal</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katia Sáez-Carrillo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Carlos González</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Apolinaria García-Cancino</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Foods</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">11(2022), 12, p 1668</subfield><subfield code="w">(DE-627)737287632</subfield><subfield code="w">(DE-600)2704223-6</subfield><subfield code="x">23048158</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:12, p 1668</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/foods11121668</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d25b83e88a874315b16fe891f0494827</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2304-8158/11/12/1668</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2304-8158</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2022</subfield><subfield code="e">12, p 1668</subfield></datafield></record></collection>
score	7.4008045

Nicht das Richtige dabei?

Schreiben Sie uns!

Consumption of a Gelatin Supplemented with the Probiotic Strain <i<Limosilactobacillus fermentum</i< UCO-979C Prevents <i<Helicobacter pylori</i< Infection in a Young Adult Population Achieved

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?